Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716
- DOI
- 10.1016/j.lungcan.2020.10.007
- Published
- 2020-12
- Container
- Lung Cancer
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.lungcan.2020.10.007,
title = {Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716},
author = {Sarah J. Danson and Joe Conner and John G. Edwards and Kevin G. Blyth and Patricia M. Fisher and Munitta Muthana and Abdulazeez Salawu and Fiona Taylor and Elizabeth Hodgkinson and Patrick Joyce and Jennifer Roman and Kathleen Simpson and Alexander Graham and Kirsty Learmonth and Penella J. Woll},
year = {2020},
journal = {Lung Cancer},
doi = {10.1016/j.lungcan.2020.10.007},
url = {https://doi.org/10.1016/j.lungcan.2020.10.007}
}RIS
TY - JOUR TI - Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716 AU - Sarah J. Danson AU - Joe Conner AU - John G. Edwards AU - Kevin G. Blyth AU - Patricia M. Fisher AU - Munitta Muthana AU - Abdulazeez Salawu AU - Fiona Taylor AU - Elizabeth Hodgkinson AU - Patrick Joyce AU - Jennifer Roman AU - Kathleen Simpson AU - Alexander Graham AU - Kirsty Learmonth AU - Penella J. Woll PY - 2020 JO - Lung Cancer DO - 10.1016/j.lungcan.2020.10.007 UR - https://doi.org/10.1016/j.lungcan.2020.10.007 ER -
APA
Danson, S. J., Conner, J., Edwards, J. G., Blyth, K. G., Fisher, P. M., Muthana, M., Salawu, A., Taylor, F., Hodgkinson, E., Joyce, P., Roman, J., Simpson, K., Graham, A., Learmonth, K., & Woll, P. J. (2020). Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716. Lung Cancer. https://doi.org/10.1016/j.lungcan.2020.10.007
Source records
- crossref · retrieved 2026-09-27T11:01:08.960Z